- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-9920
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Book Review: Anti-VEGF Use in Ophthalmology ; volume:3 ; number:1 ; day:4 ; month:9 ; year:2017 ; pages:1-2 ; date:12.2017
International Journal of Retina and Vitreous ; 3, Heft 1 (4.9.2017), 1-2, 12.2017
- Keyword
-
Augenheilkunde
Augenkrankheit
- Creator
-
Vora, Robin A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40942-017-0086-7
- URN
-
urn:nbn:de:1111-2017102618168
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Rezension
Associated
- Vora, Robin A.
- SpringerLink (Online service)
Other Objects (12)
Anti-VEGF : 13 tables
Future of anti-VEGF: biosimilars and biobetters
Anti-VEGF for the management of diabetic macular edema
Does anti-VEGF bevacizumab improve survival in experimental sepsis?
OCT-Angiographische Veränderungen bei exsudativer AMD unter anti-VEGF Therapie
Anti-VEGF drugs affect the function of pig retinal microglia
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Methodologische Analyse der anti-VEGF Therapie bei Altersbedingter Makuladegeneration (AMD)
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Anti-VEGF : 13 tables
Future of anti-VEGF: biosimilars and biobetters
Anti-VEGF for the management of diabetic macular edema
Does anti-VEGF bevacizumab improve survival in experimental sepsis?
OCT-Angiographische Veränderungen bei exsudativer AMD unter anti-VEGF Therapie
Anti-VEGF drugs affect the function of pig retinal microglia
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Methodologische Analyse der anti-VEGF Therapie bei Altersbedingter Makuladegeneration (AMD)
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
Anti-VEGF : 13 tables
Future of anti-VEGF: biosimilars and biobetters
Anti-VEGF for the management of diabetic macular edema
Does anti-VEGF bevacizumab improve survival in experimental sepsis?
OCT-Angiographische Veränderungen bei exsudativer AMD unter anti-VEGF Therapie
Anti-VEGF drugs affect the function of pig retinal microglia
Vitreomacular interface after anti-VEGF injections in diabetic macular edema
Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Methodologische Analyse der anti-VEGF Therapie bei Altersbedingter Makuladegeneration (AMD)
Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy